Seattle Genetics Announces First Patient Dosed in Phase 2 Trial of Tisotumab Vedotin Genetics Investing
Cutera Announces Expansion of FDA Indications for the truSculpt® Body Contouring System Longevity Investing
Cynata Reports Positive Six-Month Data from Cohort A in Phase 1 Trial of CYP-001 in GvHD Genetics Investing
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology Medical Device Investing
FDA Grants Priority Review to Genentech’s HEMLIBRA (emicizumab-kxwh) for People with Hemophilia A without Factor VIII Inhibitors Genetics Investing